Organisation paid for research Program year 2023 Source: CMS Open Payments

Advanced Pharma

Neither a doctor nor a teaching hospital

Research payments

$441,946

65 payments

Through program year 2023, Advanced Pharma is reported as receiving $441,946 in research payments, across 65 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2023	Research	$3,837	2
2022	Research	$334,269	31
2021	Research	$48,467	24
2020	Research	$19,501	3
2019	Research	$35,871	5

Breakdown

Who paid Research payments · program years 2019–2023

Incyte Corporation $441,946 65 payments

Studies the money was for Research payments · program years 2019–2023

A Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of INCB000928 in Participants With Impaired Renal Function and Hemodialysis $299,143 22 payments
An Open Label Phase 2 Study of INCB050465 in Participants With Primary Sjogrens Syndrome $53,856 7 payments
A Double-Blind, Vehicle-Controlled, Randomized Withdrawal and Treatment Extension Study to Assess the Long-Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo $49,073 25 payments
Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2) A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Extension Period in Participants With Vitiligo $34,519 8 payments
A Double-Blind, Vehicle-Controlled, Randomized Withdrawal and Treatment Extension Study to Assess the Long-Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo $3,837 2 payments
A Phase 2, Double Blind, Dose Ranging, Placebo Controlled Study With Open Label Extension to Evaluate the Safety and Efficacy of Itacitinib in Moderate to Severe Ulcerative Colitis $1,516 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.